Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy

Kidney International

Volumn 65, Issue 6, 2004, Pages 2193-2200

  Benigni, Ariela ^b   Gagliardini, Elena ^a   Tomasoni, Susanna ^b   Abbate, Mauro ^b   Ruggenenti, Piero ^b   Kalluri, Raghu ^b   Remuzzi, Giuseppe ^b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b NONE

Author keywords

CD2AP; Diabetes; Minimal change disease; Nephrin; Podocin; Slit diaphragm

Indexed keywords

NEPHRIN; PODOCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EVALUATION; FILTRATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MORPHOMETRICS; NEPHROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; TRANSMISSION ELECTRON MICROSCOPY;

EID: 2442652562     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00636.x     Document Type: Article

References (36)

1. U.S. RENAL DATA SYSTEM: USRDS 2000 Annual Data Report, Bethesda, MD, National Institute of Diabetes and Digestive and Kidney Diseases, 2001 (accessed March 18, 2002, at http://www. usrds.org/adr_2000.htm.)
2. EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION: Report on management of renal failure in Europe, XXVI. 1995. Nephrol Dial Transplant 11(Suppl 7):1-32, 1996
3. REMUZZI G, RUGGENENTI P, BENIGNI A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
4. RUGGENENTI P, SCHIEPPATI A, REMUZZI G: Progression, remission, regression of chronic renal diseases. Lancet 357:1601-1608, 2001
5. WILMER WA, HEBERT LA, LEWIS EJ, et al: Remission of nephrotic syndrome in type 1 diabetes: Long-term follow-up of patients in the Captopril Study. Am J Kidney Dis 34:308-314, 1999
6. REMUZZI G, SCHIEPPATI A, RUGGENENTI P: Nephropathy in patients with type 2 diabetes. N Engl J Med 346:1145-1151, 2002
7. KESTILÄ M, LENKKERI U, MÄNNIKKÖ M, et al: Positionally cloned gene for a novel glomerular protein-nephrin is mutated in congenital nephrotic syndrome. Mol Cell 1:575-582, 1998
8. LI C, RUOTSALAINEN V, TRYGGVASON K, et al: CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere. Am J Physiol Renal Physiol 279:F785-F792, 2000
9. PATRAKKA J, KESTILA M, WARTIOVAARA J, et al: Congenital nephrotic syndrome (NPHS1): Features resulting from different mutations in Finnish patients. Kidney Int 58:972-980, 2000
10. LENKKERI U, MANNIKKO M, MCCREADY P, et al: Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 64:51-61, 1999
11. BENIGNI A, TOMASONI S, GAGLIARDINI E, et al: Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 12:941-948, 2001
12. LUIMULA P, AHOLA H, WANG SX, et al: Nephrin in experimental glomerular disease. Kidney Int 58:1461-1468, 2000
13. AALTONEN P, LUIMULA P, ASTROM E, et al: Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest 8:1185-1190, 2001
14. CAO Z, BONNET F, CANDIDO R, et al: Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J Am Soc Nephrol 13:1773-1787, 2002
15. KIM BK, HONG HK, KIM JH, LEE HS: Differential expression of nephrin in acquired human proteinuric diseases. Am J Kidney Dis 40:964-973, 2002
16. FURNESS PN, HALL LL, SHAW JA, PRINGLE JH: Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant 14:1234-1237, 1999
17. PATRAKKA J, RUOTSALAINEN V, KETOLA I, et al: Expression of nephrin in pediatric kidney diseases. J Am Soc Nephrol 12:289-296, 2001
18. DOUBLIER S, RUOTSALAINEN V, SALVIDIO G, et al: Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 158:1723-1731, 2001
19. LANGHAM RG, KELLY DJ, COX AJ, et al: Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: Effects of angiotensin converting enzyme inhibition. Diabetologia 45:1572-1576, 2002
20. DOUBLIER S, SALVIDIO G, LUPIA E, et al: Nephrin expression is reduced in human diabetic nephropathy. Evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52:1023-1030, 2003
21. HAMANO Y, GRUNKEMEYER JA, SUDHAKAR A, et al: Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 277:31154-31162, 2002
22. HOLZMAN LB, ST. JOHN PL, KOVARI IA, et al: Nephrin localizes to the slit pore of the glomerular epithelial cell. Kidney Int 56:1481-1491, 1999
23. RODEWALD R, KARNOVSKY MJ: Porous substructure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol 60:423-433, 1974
24. MACCONI D, GHILARDI M, BONASSI ME, et al: Effect of angiotensin- converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J Am Soc Nephrol 11:477-489, 2000
25. ENE-IORDACHE B, IMBERTI O, FOGLIENI C, et al: Effects of angiotensin-converting enzyme inhibition on glomerular capillary wall ultrastructure in MWF/Ztm Rats. J Am Soc Nephrol 5:1378-1384, 1994
26. RUOTSALAINEN V, PATRAKKA J, TISSARI P, et al: Role of nephrin in cell junction formation in human nephrogenesis. Am J Pathol 157:1905-1916, 2001
27. PATRAKKA J, RUOTSALAINEN V, REPONEN P, et al: Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type. Transplantation 73:394-403, 2002
28. BONNET F, COOPER ME, KAWACHI H, et al: Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 44:874-877, 2001
29. KELLY DJ, AAALTONEN P, COX AJ, et al: Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: Differing effect of anti-proteinuric therapies. Nephrol Dial Transplant 17:1327-1332, 2002
30. PUTAALA H, SOININEN R, KILPELAINEN P, et al: The murine nephrin gene is specifically expressed in kidney, brain and pancreas: Inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10:1-8, 2001
31. TOPHAM PS, KAWACHI H, HAYDAR SA, et al: Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J Clin Invest 104:1559-1566, 1999
32. ORIKASA M, MATSUI K, OITE T, SHIMIZU F: Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J Immunol 141:807-814, 1988
33. HOLTHOFER H, AHOLA H, SOLIN ML, et al: Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney. Am J Pathol 155:1681-1687, 1999
34. BELTCHEVA O, KONTUSAARI S, FETISSOV S, et al: Alternatively used promotes and distinct elements direct tissue-specific expression of nephrin. J Am Soc Nephrol 14:352-358, 2003
35. BOUTE N, GRIBOUVAL O, ROSELLI S, et al: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nature Gen 24:349-354, 2000
36. SHIH NY, LI J, KARPITSKII V, et al: Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286:312-315, 2001